Concepedia

Author

John Petkau

University of British Columbia

Also Known As

J Petkau, J. John Petkau, J. PETKAU, J. Petkau, JOHN PETKAU, John Petkau, Petkau, John

80

Publications

5.9K

Citations

27

H-Index

79

Concepts

All Affiliations

University of British ColumbiaUniversity of SaskatchewanUniversity of British Columbia HospitalCentre for Advancing Health OutcomesKarolinska Institutet
JP

About

John Petkau is an author at University of British Columbia specializing in public health, multiple sclerosis, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

3.4K

2

Public Health

8

8

3.3K

3

Engineering

3

3

157

4

Business

1

1

59

5

Social Sciences

1

1

17

John Petkau

×

36

Publications

5.5K

Citations

25

H-Index

YearCitations

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen,

Neurology

2014

3K

Recommendations from the national multiple sclerosis society clinical outcomes assessment task force

Richard A. Rudick, Jack P. Antel, Christian Confavreux,

Annals of Neurology

1997

367

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Afsaneh Shirani, Yinshan Zhao, Mohammad Ehsanul Karim,

JAMA

2012

259

MRI T2 lesion burden in multiple sclerosis

DKB Li, Ulrike Held, John Petkau,

Neurology

2006

206

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Chris H. Polman, Antonio Bertolotto, Florian Deisenhammer,

The Lancet Neurology

2010

199

Acute Effects of Ambient Inhalable Particles in Asthmatic and Nonasthmatic Children

Sverre Vedal, John Petkau, Rick White,

American Journal of Respiratory and Critical Care Medicine

1998

160

Air pollution and daily mortality in a city with low levels of pollution.

Sverre Vedal, Michael Bräuer, R. E. White,

Environmental Health Perspectives

2002

130

Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b

Chris H. Polman, Ludwig Kappos, Rick White,

Neurology

2003

107

Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies

Mohammad Ehsanul Karim, Paul Gustafson, John Petkau,

American Journal of Epidemiology

2016

106

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Afsaneh Shirani, Yinshan Zhao, John Petkau,

BioMed Research International

2015

75

Page 1